PLIVA Opens New Biostudy Center in Goa


PLIVA d.d. announced the opening of its new Research and Development facility PLIVA Research (India) Private Ltd., in Goa, India, the fourth R&D center within the Group. The GOA center will be focused on conducting bioequivalence, bioavailability and pharmacokinetic studies for the company's generics product pipeline and will complement PLIVA's existing R&D capabilities established in the areas of chemistry, biotechnology and formulation development, already operating in Croatia, Poland and the Czech Republic.

The new facility currently employs over 50 employees and houses laboratories and offices totaling over 4000m2. Operations and implemented standards have been developed to meet the highest requirements for domestic and all export markets, including both the EU and US. The total investment amounted to over EUR 3m and allows for additional expansion in the future.

Zeljko ovi, PLIVA's CEO and President of the Management Board, commented: "This new biostudy center in Goa, India represents PLIVA's first greenfield investment in this country and fourth center of R&D excellence. We are excited about this opportunity as the new facility will enable PLIVA to further expand its development capacity of in-house generics products. We believe that India will play an important role in PLIVA's future R&D activities, with hopes to grow this center further".

Other news from the department business & finance

Most read news

More news from our other portals

Recognise, understand, heal: The World of Diagnostics